Cargando…
Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes
The possibility of using gene therapy for the treatment of cancer is limited by the lack of safe, intravenously administered delivery systems able to selectively deliver therapeutic genes to tumors. In this study, we investigated if the conjugation of the polypropylenimine dendrimer to lactoferrin a...
Autores principales: | Lim, Li Ying, Koh, Pei Yin, Somani, Sukrut, Al Robaian, Majed, Karim, Reatul, Yean, Yi Lyn, Mitchell, Jennifer, Tate, Rothwelle J., Edrada-Ebel, RuAngelie, Blatchford, David R., Mullin, Margaret, Dufès, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509555/ https://www.ncbi.nlm.nih.gov/pubmed/25933695 http://dx.doi.org/10.1016/j.nano.2015.04.006 |
Ejemplares similares
-
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12
por: Altwaijry, Najla, et al.
Publicado: (2018) -
Lactoferrin-Bearing Gold Nanocages for Gene Delivery in Prostate Cancer Cells in vitro
por: Almowalad, Jamal, et al.
Publicado: (2021) -
Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer Cells
por: Almowalad, Jamal, et al.
Publicado: (2022) -
Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells
por: Maeyouf, Khadeejah, et al.
Publicado: (2023) -
Transferrin‐bearing liposomes entrapping plumbagin for targeted cancer therapy
por: Sakpakdeejaroen, Intouch, et al.
Publicado: (2019)